The Potential Role of Renal Denervation in the Management of Heart Failure
Sympathetic nervous system activation in patients with heart failure is one of the main pathophysiologic mechanisms associated with the worse outcomes. Pharmacotherapies targeting neurohormonal activation have been at the center of heart failure management. Despite the advancement of therapies and t...
Main Authors: | Kameel Kassab, Ronak Soni, Adnan Kassier, Tim A. Fischell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/14/4147 |
Similar Items
-
The influence of inhibiting renal neural regeneration on the efficacy of renal denervation to chronic heart failure
by: Pingan Chen, et al.
Published: (2021-12-01) -
Renal denervation in patients with symptomatic
chronic heart failure despite resynchronization therapy – a pilot study
by: Tomasz Drożdż, et al.
Published: (2019-06-01) -
Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis
by: Zhiqiu Xia, et al.
Published: (2022-01-01) -
Clinical benefits of renal denervation besides blood pressure reduction
by: Han Chen, et al.
Published: (2018-01-01) -
Inhibiting Intestinal Krüppel-Like Factor 5 Impairs the Beneficial Role of Renal Denervation in Gut Microbiota in Rats with Heart Failure
by: Zhiqin Guo, et al.
Published: (2022-10-01)